Literature DB >> 32550985

PROTAC Compounds Targeting TRK for Use in Cancer Therapeutics.

Robert B Kargbo1.   

Abstract

Entities:  

Year:  2020        PMID： 32550985      PMCID： PMC7294544          DOI： 10.1021/acsmedchemlett.0c00235

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  5 in total

1.  Breakthroughs and challenges in the management of tropomyosin receptor kinase fusion-positive tumors.

Authors:  Hirva Mamdani; Shadia I Jalal
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Targeting tropomyosin receptor kinase for cancer therapy.

Authors:  Qi Miao; Kun Ma; Dong Chen; Xiaoxing Wu; Sheng Jiang
Journal:  Eur J Med Chem       Date:  2019-04-30       Impact factor: 6.514

3.  Larotrectinib, a selective tropomyosin receptor kinase inhibitor for adult and pediatric tropomyosin receptor kinase fusion cancers.

Authors:  Anna F Farago; George D Demetri
Journal:  Future Oncol       Date:  2020-03-04       Impact factor: 3.404

4.  Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application.

Authors:  Wei Yan; Naga Rajiv Lakkaniga; Francesca Carlomagno; Massimo Santoro; Neil Q McDonald; Fengping Lv; Naresh Gunaganti; Brendan Frett; Hong-Yu Li
Journal:  J Med Chem       Date:  2018-09-19       Impact factor: 7.446

Review 5.  NTRK Fusions in Central Nervous System Tumors: A Rare, but Worthy Target.

Authors:  Alessandro Gambella; Rebecca Senetta; Giammarco Collemi; Stefano Gabriele Vallero; Matteo Monticelli; Fabio Cofano; Pietro Zeppa; Diego Garbossa; Alessia Pellerino; Roberta Rudà; Riccardo Soffietti; Franca Fagioli; Mauro Papotti; Paola Cassoni; Luca Bertero
Journal:  Int J Mol Sci       Date:  2020-01-23       Impact factor: 5.923
  5 in total
  1 in total

Review 1.  Proteolysis Targeting Chimeras (PROTACs): A Perspective on Integral Membrane Protein Degradation.

Authors:  Camilla Ruffilli; Sascha Roth; Monica Rodrigo; Helen Boyd; Noam Zelcer; Kevin Moreau
Journal:  ACS Pharmacol Transl Sci       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.